Analysis of α1-adrenoceptor subtypes in rabbit aorta and arteries: Regional difference and co-existence

European Journal of Pharmacology

Volumn 374, Issue 2, 1999, Pages 229-240

  Satoh, Mitsutoshi ^a   Enomoto, Keisuke ^a   Takayanagi, Issei ^a   Koike, Katsuo ^a  

^a TOHO UNIVERSITY   (Japan)

Author keywords

1 Adrenoceptor; Artery, Rabbit; BMY 7378 (8 (2 (4 (2 methoxyphenyl) 1 piperazinyl)ethyl) 8 azaspirol(4,5) decane 7,9 dione dihydrochloride); Regional difference

Indexed keywords

2 [[2 (2,6 DIMETHOXYPHENOXY)ETHYL]AMINOMETHYL] 1,4 BENZODIOXAN; 8 [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] 8 AZASPIRO[4.5]DECANE 7,9 DIONE; ALPHA 1A ADRENERGIC RECEPTOR; CHLOROETHYLCLONIDINE; NORADRENALIN; NORMETADRENALIN; PHENTOLAMINE; PRAZOSIN; PROPRANOLOL; RECEPTOR SUBTYPE; YOHIMBINE; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; PIPERAZINE DERIVATIVE;

ABDOMINAL AORTA; ANIMAL TISSUE; AORTA CONSTRICTION; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; ILIAC ARTERY; MALE; MESENTERIC ARTERY; NONHUMAN; PRIORITY JOURNAL; RABBIT; RECEPTOR AFFINITY; THORACIC AORTA; VASOCONSTRICTION; ANIMAL; ARTERY; CLASSIFICATION; COMPARATIVE STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG INTERACTION; IN VITRO STUDY; METABOLISM; MUSCLE CONTRACTION; PHYSIOLOGY; PROTEIN BINDING; VASCULAR SMOOTH MUSCLE;

ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; AORTA, THORACIC; ARTERIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; MALE; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; PIPERAZINES; PRAZOSIN; PROTEIN BINDING; RABBITS; RECEPTORS, ADRENERGIC, ALPHA-1;

EID: 0032589062     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00340-4     Document Type: Article

References (50)

1. Arunlakshana O., Schild H.O. Some quantitative uses of drug antagonists. Br. J. Pharmacol. 14:1959;48-59.
2. Bevan J.A., Oriowo M.A., Bevan R.D. Physiological variation in alpha-adrenoceptor-mediated arterial sensitivity: relation to agonist affinity. Science. 234:1986;196-197.
3. 1-adrenoceptors. Eur. J. Pharmacol. 172:1989;131-145.
4. Bruno J.F., Whittaker J., Song J., Berelowtiz M. Molecular cloning and sequencing of a complementary DNA encoding a human α1A adrenergic receptor. Biochem. Biophys. Res. Commun. 179:1991;1485-1490.
5. 1B-adrenoceptor mediating contraction of the rat spleen. Br. J. Pharmacol. 115:1995;467-475.
6. Bylund D.B., Eikenberg D.C., Hieble J.P., Langer S.Z., Lefkowitz R.J., Minneman K.P., Molinoff P.B., Ruffolo R.R. Jr., Trendelenburg U. International Union of Pharmacology nomenclature of adrenoceptors. Pharmacol. Rev. 46:1994;121-136.
7. 50) of an enzymatic reaction. Biochem. Pharmacol. 22:1973;3099-3108.
8. 1-adrenergic receptor. Proc. Natl. Acad. Sci. U.S.A. 85:1988;7159-7163.
9. 1D-adrenoceptor subtype in rat myocardium, aorta and other tissues. Br. J. Pharmacol. 119:1996;269-276.
10. 1-adrenoceptor subtypes A, B and D. J. Pharm. Pharmacol. 49:1997;1091-1095.
11. 1-adrenoceptor classification. Eur. J. Pharmacol. 268:1994;141-149.
12. 1-adrenoceptors. Eur. J. Pharmacol. 272:1995;R5-6.
13. 1-adrenoceptor numbers and responses in canine aorta. Am. J. Physiol. 247:1984;H928-H935.
14. 1B-adrenoceptor binding sites in human brain tissue. Eur. J. Pharmacol. 169:1989;325-328.
15. 2+ in smooth muscle. Nature. 329:1987;333-335.
16. 1-adrenoceptors: consensus update. Pharmacol. Rev. 47:1995;267-270.
17. 1C-adrenergic receptor. Biochem. Biophys. Res. Commun. 195:1993;902-909.
18. 1D-adrenoceptor mediating the contractile response of rat aorta to noradrenaline. Br. J. Pharmacol. 115:1995;981-986.
19. Leonardi A., Hieble J.P., Guarneri L., Naselsky D.P., Poggesi E., Sironi G., Sulpizio A.C., Testa R. Pharmacological characterization of the uroselective alpha-1 antagonist Rec 15/2739 (SB 216469): role of the alpha-1L adrenoceptor in tissue selectivity, part I. J. Pharmacol. Exp. Ther. 281:1997;1272-1283.
20. 1A subtype in rat submaxillary gland. Br. J. Pharmacol. 98:1989;883-889.
21. 1-adrenergic receptor subtypes distinguished by chloroethylclonidine and WB 4101. Mol. Pharmacol. 33:1988;509-514.
22. 3H ]prazosin binding Mol. Pharmacol. 29:1986;321-330.
23. Munson P.J., Rodbard D. LIGAND: a versatile computerized approach for characterization of ligand-binding systems. Anal. Biochem. 107:1980;220-239.
24. 1-adrenoceptors in vascular smooth muscle. Br. J. Pharmacol. 99:1990;197-201.
25. 1-adrenoceptor subtype mRNAs in human proximal urethra. Br. J. Pharmacol. 123:1998;1289-1293.
26. Oriowo M.A., Bevan J.A., Bevan R.D. Variation in sensitivity of alpha adrenoceptor-mediated contraction of the vascular smooth muscle of rabbit elastic and muscular arteries is related to receptor affinity. J. Pharmacol. Exp. Ther. 241:1987;239-244.
27. Oriowo M.A., Bevan R.D., Bevan J.A. Vascular α-adrenoceptor affinity variation is not due to varying populations of subtypes distinguished by WB 4101 and chlorethylclonidine. Eur. J. Pharmacol. 216:1992;415-420.
28. 1-adrenergic receptor subtype classification. Mol. Pharmacol. 46:1994;221-226.
29. Ramarao C.S., Denker J.M., Perez D.M., Gaivin R.J., Riek R.P., Graham R.M. Genomic organization and expression of the human alpha 1B adrenergic receptor. J. Biol. Chem. 267:1992;21936-21945.
30. 3H ]prazosin in single cells prepared from rabbit thoracic aorta Eur. J. Pharmacol. 221:1992;35-41.
31. 1-agonists, norepinephrine and clonidine, by selective antagonists of their subtypes in rabbit thoracic aorta. Jpn. J. Pharmacol. 60:1992;169-177.
32. 1-adrenoceptor subtypes and mechanisms in rabbit arteries. Eur. J. Pharmacol. 350:1998;67-73.
33. 1 subtype. Can. J. Physiol. Pharmacol. 72(Sup. 1):1994;323.
34. Scatchard G. The attractions of proteins for small molecules and ions. Ann. N. Y. Acad. Sci. 51:1949;660-672.
35. Scofield M.A., Liu F., Abel P.W., Jeffries W.B. Quantification of steady state expression of mRNA for alpha-1 adrenergic receptor subtypes using reverse transcription and a competitive polymerase chain reaction. J. Pharmacol. Exp. Ther. 275:1995;1035-1042.
36. Shoji T., Tsuru H., Shigei T. A regional difference in the distribution of postsynaptic alpha-adrenoceptor subtypes in canine veins. Naunyn-Schmiedeberg's Arch. Pharmacol. 324:1983;246-255.
37. 2+ signalling mechanism and plays a different physiological role. Mol. Pharmacol. 38:1990;725-736.
38. 1d-adrenoceptor. Biochem. Biophys. Acta. 1323:1997;6-11.
39. 1-adrenoceptor mechanism in canine veins. Arch. Int. Pharmacodyn. Ther. 289:1987;106-117.
40. 1-adrenoceptor in canine arteries. Arch. Int. Pharmacodyn. Ther. 294:1988;175-184.
41. 1-adrenoceptor mechanisms for phenylephrine and tizanidine in rabbit thoracic aorta and common iliac artery. Can. J. Physiol. Pharmacol. 49:1991;1819-1824.
42. 1-adrenoceptor mechanisms in rabbit arteries. Jpn. J. Pharmacol. 55:1991;513-522.
43. 1d-adrenoceptor subtype is involved in the noradrenaline-induced contractions of rat aorta. Life Sci. 57:1995;PL159-163.
44. Testa R., Guarneri L., Angelico P., Poggesi E., Taddei C., Sironi G., Colombo D., Sulpizio A.C., Naselsky D.P., Hieble J.P., Leonardi A. Pharmacological characterization of the uroselective alpha-1 antagonist Rec 15/2739 (SB 216469): role of the alpha-1L adrenoceptor in tissue selectivity, part II. J. Pharmacol. Exp. Ther. 281:1997;1284-1293.
45. 2+ influx. Mol. Pharmacol. 36:1989;166-176.
46. 1-adrenoceptors in rabbit lower urinary tract and mesenteric artery. Eur. J. Pharmacol. 327:1997;25-32.
47. 1A subtypes. Eur. J. Pharmacol. 298:1996;257-263.
48. Voigt M.M., Kispert J., Chin H. Sequence of a rat brain cDNA encoding an alpha-1B adrenergic receptor. Nucleic Acids Res. 18:1990;1053.
49. Wada T., Otsu T., Hasegawa Y., Mizuchi A., Ono H. Characterization of alpha 1-adrenoceptor subtypes in rat spinal cord. Eur. J. Pharmacol. 312:1996;263-266.
50. 1A type. Jpn. J. Pharmacol. 62:1993;297-304.